Primary Myelofibrosis - 13 Studies Found

Terminated : A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial)
: Primary Myelofibrosis
: 2014-03-06
: Drug: Ruxolitinib Starting dose was based on reason for previous discontinuation of ruxolitinib (i.e. lo
Completed : Thalidomide in Treating Patients With Myelofibrosis
: Primary Myelofibrosis
: 2001-05-06
:
  • Drug: thalidomide Given PO
Withdrawn : A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis
: Primary Myelofibrosis
: 2015-10-21
: Biological: Pacritinib QD (Once a day)
Active, not recruiting : Decitabine in Treating Patients With Myelofibrosis
:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    : 2004-11-09
    :
    • Drug: Decitabine Given SC
Recruiting : P1101 in Treating Patients With Myelofibrosis
:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    : 2015-02-17
    :
    • Other: Laboratory Biomarker Analysis

Active, not recruiting : Phase-3 Double-Blind, Placebo-Controlled Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence Myelofibrosis and RBC-Transfusion-Dependence
: Primary Myelofibrosis
: 2010-07-15
:
  • Drug: Pomalidomide 0.5 mg Poma
Completed : Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    : 2016-09-26
    :
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed : A Clinical Study of Ruxolitinib in Patients With Primary Myelofibrosis (PM), Post-polycythemia Vera (PV) Myelofibrosis, or Post-essential Thrombocythemia (ET) Myelofibrosis
: Primary Myelofibrosis (MF)
: 2014-03-12
: Drug: Ruxolitinib
Recruiting : JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
:
  • Primary Myelofibrosis
  • Secondary Myelofibr
    : 2014-09-12
    :
    • Procedure: Allogeneic Hematopoietic Stem Cell Transplantation

Completed : A Phase 2 Study With IPI-926 in Patients With Myelofibrosis
:
  • Primary Myelofibrosis
  • Fibrosis, Bone Marrow

: 2011-06-09
: Drug: IPI-926 Single Arm study of oral IPI-926 at 160 mg, 130 mg or 110 mg daily, until progressive dise
Next >>>